HomeAI · summaries
Storia in 2 fonti
Zydus Lifesciences Q4 profit rises 8.7% to ₹1,272 crore; announces ₹1,100 crore buyback
Zydus Lifesciences Limited reported an 8.7% year-on-year increase in consolidated net profit that stood at ₹1,272 crore for the quarter ended March 2026, impacted by a one-time expense related to the Mirabegron litigation settlement.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
thehindubusinessline.com
Zydus Lifesciences Q4 profit rises 8.7% to ₹1,272 crore; announces ₹1,100 crore buyback
Zydus Lifesciences Limited reported an 8.7% year-on-year increase in consolidated net profit that stood at ₹1,272 crore for the quarter ended March 2026, impacted by a one-time…
- ·
economictimes.indiatimes.com
Zydus Lifesciences' Rs 1,100 crore share buyback at 13% premium: Check record date, other details
Zydus Lifesciences is launching its largest share buyback program to date. The company plans to repurchase shares worth Rs 1,100 crore. This move offers shareholders a premium…
